ArticleFrontiers in pediatrics2025
Nomograms for postoperative complications in congenital biliary dilatation: a retrospective cohort study.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Postoperative complications after surgery for congenital biliary dilatation (CBD) can be life-threatening and often necessitate redo surgery. We aimed to predict postoperative complications in patients with CBD using machine learning (ML) algorithms. Study design: Data from pediatric patients with CBD who were surgically treated at our hospital between July 2014 and July 2023 was retrospectively analyzed. Multiple logistic regression and lasso regression were used to screen risk factors. Predictive models were developed using seven ML algorithms and the better-performing model was selected. Results: A total of 211 patients were included in the final analysis. Among these, 31 patients experienced complications (cholangitis: 14 patients; pancreatitis: 21 patients).Risk factors for complications identified by variable screening were preoperative perforation, Todani classification type IV-A (type 4A), days of removal of drainage (removal drainage), and serum amylase. Predictors of postoperative cholangitis were preoperative perforation, preoperative cholangitis, type 4A, removal drainage, anemia, level of serum albumin and amylase. Preoperative perforation, cholangitis, serum gamma-glutamyl transferase and amylase were predictors of postoperative pancreatitis. Finally, logistic regression was selected to develop the clinical prediction model for postoperative complications, cholangitis, and pancreatitis. Conclusions: We developed nomograms to predict postoperative complications, cholangitis, and pancreatitis after surgery for CBD using ML.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.